Pharmaceutical News

RSS

Study shows adequate sleep may accelerate antidepressant treatment response

Medication is an important part of treatment for many patients with major depressive disorder, but the transition to antidepressants isn't always smooth.

7 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

Beta-blockers can help treat bone loss caused by antidepressants in mice

The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.

7 Sep 2016

Psychopharmacological intervention shows promise in treating children with dyslexia

A new study shows significant improvement in critical components of reading, including decoding and vocabulary, among children treated with atomoxetine compared to placebo.

7 Sep 2016

Study looks at criminal element of performance enhancing drug market among bodybuilders

Many bodybuilders illegally sell steroids to help fund their own use of performance and image enhancing drugs and maintain their social status in the weightlifting community, a new academic study has found.

7 Sep 2016

Schizophrenia drug slows pancreatic tumor growth in mice

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

7 Sep 2016

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Antibiotic-resistant bacteria, known as "superbugs," pose a major public health threat.

7 Sep 2016

Study highlights need for additional systems to report adverse drug reactions in infants

A new study reveals that adverse drug reactions in newborns and infants may be under-reported.

7 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

Simple saline solution could help alleviate chronic nosebleeds, study shows

Squirting a simple saline solution into the nose twice a day could alleviate chronic nosebleeds just as effectively as spraying with any one of three different medications, reports a study published online in the Journal of the American Medical Association on Sept. 6.

7 Sep 2016

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.

7 Sep 2016

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in China.

6 Sep 2016

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited condition characterized by abnormal blood vessels which are delicate and prone to bleeding.

6 Sep 2016

Oral vitamin D supplement may reduce risk of severe asthma attacks

A new Cochrane Review, published in the Cochrane Library today and presented at the ERS International Congress, has found evidence from randomised trials, that taking an oral vitamin D supplement in addition to standard asthma medication is likely to reduce severe asthma attacks.

6 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

Dengue vaccine may worsen infections if used in areas with low rates of disease

The world's only licensed vaccine for dengue may worsen subsequent dengue infections if used in areas with low rates of dengue infection, suggests new research.

6 Sep 2016

Researchers identify potential new way of treating hypertension

Researchers eyeing first new anti-hypertensive drug treatment strategy in more than 15 years.

6 Sep 2016

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

A team of scientists led by Dr Bhaskar Bhattacharya and Associate Professor Richie Soong from the Cancer Science Institute of Singapore at the National University of Singapore conducted a study on acquired resistance (AQR) to combination drug treatment in cancer and found that the mechanisms of AQR for the combination drugs were different from that of the individual drugs.

6 Sep 2016

Research findings pave way to better tailored treatment for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments tailored to patients' disease for the first time.

6 Sep 2016

Researchers use unique computational approach to identify promising drug leads for heart diseases

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure.

6 Sep 2016

Pharmaceutical News

Study shows adequate sleep may accelerate antidepressant treatment response

Researchers unlock genetic code that disrupts response to breast cancer therapy

Beta-blockers can help treat bone loss caused by antidepressants in mice

Psychopharmacological intervention shows promise in treating children with dyslexia

Study looks at criminal element of performance enhancing drug market among bodybuilders

Schizophrenia drug slows pancreatic tumor growth in mice

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Study highlights need for additional systems to report adverse drug reactions in infants

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Simple saline solution could help alleviate chronic nosebleeds, study shows

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Oral vitamin D supplement may reduce risk of severe asthma attacks

New drug holds potential for treating advanced mastocytosis

Dengue vaccine may worsen infections if used in areas with low rates of disease

Researchers identify potential new way of treating hypertension

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

Research findings pave way to better tailored treatment for oesophageal cancer

Researchers use unique computational approach to identify promising drug leads for heart diseases

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News